Markets:

Overview

News

Currencies

International

Treasuries

Adaptimmune Therapeutics plc - American Depositary Shares (NQ:ADAP)

0.0549 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 27, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Adaptimmune Therapeutics plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Adaptimmune Therapeutics: Q4 Earnings Insights ↗

March 14, 2022

Adaptimmune Therapeutics (NASDAQ:ADAP) reported its Q4 earnings results on Monday, March 14, 2022 at 07:30 AM. Here's what investors need to know about the announcement...

Via Benzinga

Earnings Scheduled For March 14, 2022 ↗

March 14, 2022

Companies Reporting Before The Bell • F45 Training Holdings (NYSE:FXLV) is projected to report earnings for its fourth quarter. • The One Group Hospitality (...

Via Benzinga

A Preview Of Adaptimmune Therapeutics's Earnings ↗

March 11, 2022

Adaptimmune Therapeutics (NASDAQ:ADAP) is set to give its latest quarterly earnings report on Monday, 2022-03-14. Here's what investors need to know before the announcement....

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗

July 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...

Via Benzinga

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings ↗

March 13, 2022

Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 21, 2022

Gainers Mustang Bio (NASDAQ:MBIO) shares ...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

March 02, 2022

Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by...

Via Benzinga

Why Adaptimmune Therapeutics Stock Is Crashing Today ↗

December 01, 2021

Investor sentiment has turned against this promising cell therapy company.

Via The Motley Fool

Adaptimmune Bullish On Meeting Endpoint For Soft Tissue Cancer Trial ↗

November 11, 2021

Adaptimmune Therapeutics plc (NASDAQ: ADAP) will report updated data from its SPEARHEAD-1 Phase 2 trial with afamitresgene autoleucel (afami-cel, ADP-A2M4) in...

Via Benzinga

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

Adaptimmune Therapeutics plc (ADAP) Q3 2021 Earnings Call Transcript ↗

November 04, 2021

ADAP earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Adaptimmune Therapeutics: Q3 Earnings Insights ↗

November 04, 2021

Adaptimmune Therapeutics (NASDAQ:ADAP) reported its Q3 earnings results on Thursday, November 4, 2021 at 08:00 AM. Here's what investors need to know about the...

Via Benzinga

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗

October 24, 2021

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...

Via Benzinga

Why Adaptimmune Therapeutics Was Sinking This Week ↗

September 17, 2021

Profit-taking seemed to be the general dynamic behind the biotech's 14% slide.

Via The Motley Fool

Looking Into Adaptimmune Therapeutics's Return On Capital Employed ↗

September 14, 2021

Adaptimmune Therapeutics (NASDAQ:ADAP) brought in sales totaling $3.10 million during Q2 according to data provided by Benzinga Pro.However, earnings decreased 4.22%, resulting in...

Via Benzinga

Adaptimmune Shares Encouraging Data From Solid Tumor Trial ↗

September 13, 2021

Adaptimmune Therapeutics plc (NASDAQ: ADAP) has announced updated data from its Phase 1 SURPASS trial in multiple solid tumors evaluating ADP-A2M4CD8. ADP-A2M4CD8...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 13, 2021

Gainers Itamar Medical (NASDAQ:ITMR) shares moved upwards by 44.37% to $29.8 during Monday's pre-market session. The market value of their outstanding shares is at $...

Via Benzinga

Mid-Afternoon Market Update: Dow Falls Over 200 Points; RenovoRx Shares Spike Higher ↗

September 07, 2021

Toward the end of trading Tuesday, the Dow traded down 0.65% to 35,138.64 while the NASDAQ rose 0.13% to 15,383.18. The S&P also fell, dropping 0.27% to 4,522.99. The U.S. has...

Via Benzinga

Topics Stocks

72 Biggest Movers From Yesterday ↗

September 08, 2021

Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth....

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 07, 2021

Gainers Surrozen (NASDAQ:SRZN) stock rose 33.14% to $9.64 during Tuesday's regular session. The company's market cap stands at $351.2 million. ZIOPHARM Oncology (...

Via Benzinga

45 Stocks Moving In Tuesday's Mid-Day Session ↗

September 07, 2021

Gainers IronNet, Inc. (NYSE: IRNT) shares jumped 50.4% to $25.06 after jumping over 23% on Friday. Mechel PAO (NYSE: MTL) shares jumped 32.6% to $4.2443. The company recently...

Via Benzinga

Why Adaptimmune Therapeutics Stock Is Bolting Higher Today ↗

September 07, 2021

A major licensing deal with cancer giant Roche is pushing the biotech's shares higher this morning.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 07, 2021

Gainers Pliant Therapeutics (NASDAQ:PLRX) shares rose 25.62% to $24.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $872.2...

Via Benzinga

Adaptimmune Stock Moves Higher On Cancer Deal With Genentech ↗

September 07, 2021

Adaptimmune Therapeutics plc (NASDAQ: ADAP) has announced a collaboration and license agreement with Genentech, a unit of Roche Holdings AG (OTC:...

Via Benzinga

Why Adaptimmune Therapeutics Stock Is Spiking Today ↗

August 23, 2021

The hunt for the next biotech buyout play is apparently underway.

Via The Motley Fool

Adaptimmune Therapeutics plc (ADAP) Q2 2021 Earnings Call Transcript ↗

August 09, 2021

ADAP earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts ↗

July 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...

Via Benzinga

The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay ↗

July 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Alnylam Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street ↗

July 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.